What it is best to know:

– AKASA, a pacesetter in generative AI (GenAI) options for the income cycle, at this time introduced the launch of Authorization Advisor™.

– Authorization Advisor tackles the time-consuming and error-prone technique of prior authorization, a significant ache level for healthcare suppliers.

Prior authorization made straightforward with AI

Prior authorization, a course of that requires approval from insurers earlier than offering sure companies, locations a big burden on healthcare suppliers. It prices income cycle groups an amazing period of time and infrequently delays affected person care. Authorization Advisor tackles this problem head-on and provides the chance to cut back authorization processing time by as much as 50%. This progressive GenAI instrument provides prior authorization specialists quite a few key options:

• Interactive sidebar view: Offers real-time entry to affected person information and curated scientific documentation instantly throughout the payer portal workflow.
• Safe and correct information entry: Ensures affected person info is accomplished appropriately on the payer portal.
• AI-powered doc advice: Recommends related scientific paperwork to assist authorization requests, eliminating guide searches and enhancing accuracy.
• Lowered guide workload: Eliminates the necessity to type by mountains of paperwork, releasing up invaluable time for specialists.

Healthcare system-specific AI mannequin for accuracy

AKASA's distinctive strategy makes use of a healthcare system-specific AI mannequin skilled on the group's personal scientific and monetary information. This ensures that the AI ​​assistant understands the particular nuances of every healthcare system, not like generic AI fashions. In truth, AKASA's fashions have been proven to be 38% extra correct than generic variations in deciding on related prior authorization paperwork.

By eliminating guide doc searches and suggesting related supporting documentation, Authorization Advisor considerably reduces the executive burden for affected person entry groups. This not solely saves time, but in addition ensures correct authorization submissions, resulting in sooner approvals and improved money circulate for healthcare suppliers.

“Healthcare leaders are continually attempting to pivot each method attainable to have a constructive influence on our folks, processes and sufferers,” mentioned John Fox, former president and CEO of Emory and Beaumont Well being, and advisor at AKASA. “AKASA is innovating in healthcare with these new generative AI instruments. They’re in the appropriate place on the proper time to actually rework the income cycle by lowering friction and driving actual outcomes.”